# ANalgesic Efficacy and Safety of MOrphiNe Versus Methoxyflurane in Patients With Acute Myocardial Infarction

> **NCT04476173** · PHASE3 · UNKNOWN · sponsor: **Collegium Medicum w Bydgoszczy** · enrollment: 200 (estimated)

## Conditions studied

- ST Elevation Myocardial Infarction
- Non ST Segment Elevation Acute Coronary Syndrome

## Interventions

- **DRUG:** Methoxyflurane - Penthrox
- **DRUG:** Morphine

## Key facts

- **NCT ID:** NCT04476173
- **Lead sponsor:** Collegium Medicum w Bydgoszczy
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-01
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04476173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04476173, "ANalgesic Efficacy and Safety of MOrphiNe Versus Methoxyflurane in Patients With Acute Myocardial Infarction". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04476173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*